跳至主要内容
临床试验/JPRN-jRCTs031190054
JPRN-jRCTs031190054已完成未知

In vivo quantification of central phosphodiesterase 7 using [11C]MTP38

Tagai Kenji0 个研究点目标入组 7 人开始时间: 2019年7月12日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
7

研究概览

简要总结

The distribution of [11C]MTP38 is consistent with that of PDE7, and kinetic analysis using arterial blood samples showed that it could be quantified by the reference tissue method, indicating that it is a promising ligand for clinical use.Besides, the investigation in combination with MRI suggested that it is useful for voxel-based analysis and applied analysis with MRI.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 50age old(—)
性别
Male

入选标准

  • Healthy male subjects

排除标准

  • 1.Subjects who do not have ability to make informed consent.
  • 2. Subjects with any psychiatric disorder or subjects with severe physical complication.
  • 3. Subjects who currently smokes.
  • 4. Subjects with any organic brain disorder.
  • 5. Subjects with metallic medical device in the body.
  • 6. Subjects with tattoo.
  • 7. Subjects with severe claustrophobia.
  • 8. Subjects with a history of allergy to heparin and local anesthetics.
  • 9. Subjects who are taking an anticoagulant.
  • 10. Subjects who has participated in other study in recent 6 months.
  • 11. Subjects who has participated in blood donation in recent 12 weeks.
  • 12. Subjects who is considered to be inappropriate to participate in the study.

研究者

发起方
Tagai Kenji

相似试验